Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Afghan Kush is a legendary landrace cannabis strain originating from the Hindu Kush mountain range along the Afghanistan-Pakistan border. It is a pure or nearly pure indica variety, renowned for its heavy resin production and deeply sedating effects. Afghan Kush has been cultivated and stabilized over centuries in its native region, making it one of the foundational strains for traditional hashish production such as charas and Afghani hash[1][3][6]. The strain typically features high THC content (ranging from 16% to 21%) and moderate CBD levels (up to 6%), resulting in potent physical relaxation, pain relief, appetite stimulation, and sleep induction[2][6][7]. Its aromatic profile is earthy, woody, with spicy herbal undertones; dominant terpenes include myrcene, caryophyllene, and pinene[1][5]. Afghan Kush is widely used both recreationally for relaxation and medically for conditions such as chronic pain, insomnia, anxiety/stress disorders, loss of appetite/nausea management[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on afghan kush.